The global economy’s fluctuations in 2026, characterized by shifting trade policies and "Most Favored Nation" (MFN) drug pricing reforms in the US, have created a complex environment for biopharma. The Restless Legs Syndrome Market Economic Outlook remains cautiously optimistic, as the "essential" nature of sleep health protects the market from the worst of discretionary spending...

  Restless Legs Syndrome (RLS) is a neurological condition that causes unpleasant sensations in the legs and an uncontrollable urge to move them, particularly during rest or nighttime. This disorder significantly affects sleep quality, leading to fatigue, reduced productivity, and diminished overall well-being. As awareness of neurological and sleep-related disorders continues to rise,...